Nanoform Finland (Finland) Performance
| NANOFH Stock | EUR 1.27 0.04 3.25% |
The company secures a Beta (Market Risk) of 0.52, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nanoform Finland's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nanoform Finland is expected to be smaller as well. At this point, Nanoform Finland Plc has a negative expected return of -0.26%. Please make sure to verify Nanoform Finland's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Nanoform Finland Plc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Nanoform Finland Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 61 M | |
| Total Cashflows From Investing Activities | -9.1 M |
Nanoform |
Nanoform Finland Relative Risk vs. Return Landscape
If you would invest 157.00 in Nanoform Finland Plc on September 29, 2024 and sell it today you would lose (30.00) from holding Nanoform Finland Plc or give up 19.11% of portfolio value over 90 days. Nanoform Finland Plc is generating negative expected returns and assumes 4.3678% volatility on return distribution over the 90 days horizon. Simply put, 38% of stocks are less volatile than Nanoform, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Nanoform Finland Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nanoform Finland's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nanoform Finland Plc, and traders can use it to determine the average amount a Nanoform Finland's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.059
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NANOFH |
Estimated Market Risk
| 4.37 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nanoform Finland is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nanoform Finland by adding Nanoform Finland to a well-diversified portfolio.
Nanoform Finland Fundamentals Growth
Nanoform Stock prices reflect investors' perceptions of the future prospects and financial health of Nanoform Finland, and Nanoform Finland fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nanoform Stock performance.
| Return On Equity | -0.24 | |||
| Return On Asset | -0.13 | |||
| Operating Margin | (6.75) % | |||
| Current Valuation | 194.87 M | |||
| Shares Outstanding | 78.39 M | |||
| Price To Book | 2.85 X | |||
| Price To Sales | 84.43 X | |||
| Revenue | 1.95 M | |||
| EBITDA | (17.19 M) | |||
| Cash And Equivalents | 94.82 M | |||
| Cash Per Share | 1.31 X | |||
| Total Debt | 6.68 M | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | 1.18 X | |||
| Cash Flow From Operations | (14.35 M) | |||
| Earnings Per Share | (0.30) X | |||
| Total Asset | 99.35 M | |||
About Nanoform Finland Performance
By analyzing Nanoform Finland's fundamental ratios, stakeholders can gain valuable insights into Nanoform Finland's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nanoform Finland has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nanoform Finland has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nanoform Finland Oy provides nanotechnology and drug particle engineering services for the pharmaceutical and biotechnology industries in Finland and internationally. The company was founded in 2015 and is headquartered in Helsinki, Finland. Nanoform Finland operates under Biotechnology classification in Finland and is traded on Helsinki Exchange. It employs 87 people.Things to note about Nanoform Finland Plc performance evaluation
Checking the ongoing alerts about Nanoform Finland for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nanoform Finland Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nanoform Finland Plc generated a negative expected return over the last 90 days | |
| Nanoform Finland Plc may become a speculative penny stock | |
| Nanoform Finland Plc has high historical volatility and very poor performance | |
| The company reported the revenue of 1.95 M. Net Loss for the year was (19.69 M) with profit before overhead, payroll, taxes, and interest of 1.79 M. | |
| Nanoform Finland Plc has accumulated about 94.82 M in cash with (14.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Nanoform Finland's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nanoform Finland's stock is overvalued or undervalued compared to its peers.
- Examining Nanoform Finland's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nanoform Finland's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nanoform Finland's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nanoform Finland's stock. These opinions can provide insight into Nanoform Finland's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nanoform Stock analysis
When running Nanoform Finland's price analysis, check to measure Nanoform Finland's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanoform Finland is operating at the current time. Most of Nanoform Finland's value examination focuses on studying past and present price action to predict the probability of Nanoform Finland's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanoform Finland's price. Additionally, you may evaluate how the addition of Nanoform Finland to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |